Reports that researchers have found a way to display a protein crucial for cell-mediated immunity, the T cell receptor (TCR) on surface of yeast cells. Possibility of engineering high-affinity forms of the protein for therapeutic applications; Findings that mutations in two region of the TCR allowed it to be expressed on the yeast surface at high levels; Possible use of the TCR engineering in treating autoimmune diseases.